4//SEC Filing
Cundy Kenneth C 4
Accession 0001493152-22-016081
CIK 0001815974other
Filed
Jun 6, 8:00 PM ET
Accepted
Jun 7, 4:10 PM ET
Size
5.5 KB
Accession
0001493152-22-016081
Insider Transaction Report
Form 4
Cundy Kenneth C
Chief Scientific Officer
Transactions
- Award
Option to purchase Common Stock
2022-06-01+350,169→ 350,169 totalExercise: $2.91From: 2022-07-01Exp: 2027-06-30→ Common Stock (350,169 underlying)
Footnotes (1)
- [F1]Mr. Cundy received a stock option to purchase shares of the Issuer's common stock pursuant to the Issuer's 2020 Stock Incentive Plan: (a) 233,446 shares will vest in equal quarterly installments from July 1, 2022 through April 1, 2026. (b) 116,723 shares will vest upon completion of certain milestone events.
Documents
Issuer
Anebulo Pharmaceuticals, Inc.
CIK 0001815974
Entity typeother
Related Parties
1- filerCIK 0001322959
Filing Metadata
- Form type
- 4
- Filed
- Jun 6, 8:00 PM ET
- Accepted
- Jun 7, 4:10 PM ET
- Size
- 5.5 KB